• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Enrollment process offers key opportunities

Article

The enrollment process offers opportunities to engage employees, but the tools themselves are not enough, according to one industry expert.

"The data behind the tool, as well as a well-orchestrated campaign that supports the messages and behaviors is needed for success," says Jeri Stepman, Watson Wyatt's national leader for health and welfare administration.

"It also is important to define success since we realize that not all employees will engage in this process," Stepman adds.

"The enrollment process is a key opportunity to get the attention of your participants," she says. "If the desire is to increase participation in the health-risk assessment, integration with annual enrollment in a way that makes it easy for employees to access the tool and receive the results will foster that result."

Tying risk assessments into the enrollment process helps avoid duplication of reported data fields from the members, resulting in improved accuracy, according to Clive Riddle, president and founder of MCOL, a provider of business-to-business health management and managed care resources in Modesto, Calif.

"The data reported during enrollment will tend to be more accurate than when self-reported for other purposes during other times of the year," Riddle says. "A number of health plans are now capturing health-risk-assessment data for predictive modeling purposes, to identify specific candidates for care management among other objectives.

"By incorporating health-risk assessments into the enrollment process, additional demographic data is available from the same data source, with a greater degree of accuracy, all of which improves the predictive modeling process as well," he adds.

Incorporating incentives for participation in risk assessments that relate to enrollment options can further enhance and leverage a risk-assessment enrollment process strategy, according to Riddle. "Perhaps the strongest motivator is a premium-contribution reduction for participation, which directly ties into the enrollment process," he says.

The Department of Labor has recently issued a checklist and guidelines for how to development such wellness incentive programs that are compliant from a regulatory perspective.

"A challenge with tying any program to the enrollment process is that unfortunately the standard in the employer marketplace is still to allow retroactive enrollments and disenrollments, and these transactions need to be taken into consideration when administering risk assessments," Riddle says.

Stepman offers this final thought: "Implement an enrollment process that allows for targeted messaging, seamless integration of tools and process and the flexibility to roll-in new features and functions. Annual enrollment is a communication opportunity that should not be missed."

Related Videos
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Related Content
© 2024 MJH Life Sciences

All rights reserved.